Health Encyclopedia

Limb-girdle muscular dystrophies

Definition

Limb-girdle muscular dystrophies include at least 10 different inherited disorders, which initially affect the muscles around the shoulder girdle and the hips. These diseases are progressive and may involve other muscles over a period of time.

Alternative Names

Muscular dystrophy - limb-girdle type

Causes, incidence, and risk factors

This is a large group of genetic diseases featuring muscle weakness and wasting (muscular dystrophy). Most are inherited in an autosomal recessive manner (both parents must pass on the defective gene for a child to have the disease), but some are autosomal dominant (only one parent needs to pass on the bad gene to affect the child). For some of these conditions, the defective gene has been discovered, but for others, the gene is not yet known.

Typically, the first sign is pelvic muscle weakness (difficulty standing from a sitting position without using arms, difficulty climbing stairs), which starts in childhood to young adulthood. Later there is the shoulder weakness. The disease will cause significant loss of mobility or wheelchair dependence over the next 20-30 years.

An important risk factor is having a family member with muscular dystrophy.

Symptoms

Muscle weakness in pelvis, hips, upper legs, shoulders
Loss of muscle mass in the same areas, thinning of those body parts
Low back pain
Abnormal, sometimes waddling, gait while walking
Later in disease, there can be facial muscle weakness
Later in the disease, muscles of the lower legs, feet, lower arms, and hands can become weak
Late in the disease, there can be contractures of joints (they become fixed in a contracted position)
Palpitations or passing out spells can be caused by abnormal heart rhythms
Sometimes the calves will look large and muscular (pseudohypertrophy), but they are actually not strong

Signs and tests

Normal muscle biopsy for dystrophin (the protein that is defective in the more common Duchenne muscular dystrophy)
Electromyogram (EMG) testing shows a pattern called myopathy, sick and dying muscle fibers
High blood creatine kinase levels
Muscle biopsy shows deteriorating muscle, with splitting of muscle fibers and the presence of cells of the immune system (phagocytes), which are not normally present
In some less common muscular dystrophies, the heart may show weakness (heart failure) on echocardiogram, or an abnormal rhythm on ECG

Treatment

There are no known treatments that directly reverse the muscle weakness. Gene therapy may become available in the future. Supportive treatment can decrease the complications of the disease.

Support Groups

The Muscular Dystrophy Association is an excellent resource (800-572-1717).

Expectations (prognosis)

This is a large group of related but separate diseases. In general, it is expected that there will be slow progression of weakness, which worsens in affected muscles, spreads, and worsens further.

Heart muscle weakness and the tendency to have abnormal electrical activity of the heart can increase the risk of palpitations, fainting and sudden death. Most patients with this group of diseases live into adulthood, but do not reach their full life expectancy.

Complications

Progressive weakness, which results in requiring a wheelchair
Difficulties with activities of daily living due to shoulder weakness
Contractures due to decreased muscle movements and joint use
Abnormal heart rhythms

Calling your health care provider

Call your health care provider if you or your child note weakness while rising from a squatting position. Call a geneticist if you or a family member have a diagnosis of muscular dystrophy and you are planning a pregnancy.

Prevention

Genetic counseling may help prevent some cases. Some of the complications can be prevented by appropriate treatment. For example, a cardiac pacemaker or defibrillator can significantly reduce the risk of sudden death due to an abnormal heart rhythm. Physical therapy may be able to prevent and/or delay contractures.

Review Date:8/11/2006
Reviewed By:Brian Kirmse, MD, Mount Sinai School of Medicine, Department of Human Genetics, New York, NY. Review provided by VeriMed Healthcare Network.

ADAM Quality A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org). URAC's accreditation program is the first of its kind, requiring compliance with 53 standards of quality and accountability, verified by independent audit. A.D.A.M. is among the first to achieve this important distinction for online health information and services. Learn more about A.D.A.M.'s editorial process. A.D.A.M. is also a founding member of Hi-Ethics (www.hiethics.com) and subscribes to the principles of the Health on the Net Foundation (www.hon.ch).

The Agency for Health Care Administration (Agency) and this website do not claim the information on, or referred to by, this site is error free. This site may include links to websites of other government agencies or private groups. Our Agency and this website do not control such sites and are not responsible for their content. Reference to or links to any other group, product, service, or information does not mean our Agency or this website approves of that group, product, service, or information.

Additionally, while health information provided through this website may be a valuable resource for the public, it is not designed to offer medical advice. Talk with your doctor about medical care questions you may have.